Navigation Links
Sysmex America Signs Distributorship Agreement With LABSCO
Date:4/19/2011

MUNDELEIN, Ill., April 19, 2011 /PRNewswire/ -- Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, announced today an amended distributorship agreement with Laboratory Supply Company (LABSCO).  This agreement, which automatically renews for up to four successive one-year periods, is for Sysmex reagents, controls and instruments including the Sysmex pocH-100i™, Sysmex KX-21N™, the Sysmex XS-1000i™, XT-Series and XE-Series Automated Hematology Analyzers.  The agreement is effective immediately and continues until March 31, 2015.  This agreement represents Sysmex America's second amended distributorship agreement with LABSCO.  

"Sysmex America has enjoyed a successful partnership with LABSCO for several years built on trust, confidence and collaboration.  LABSCO's clinical lab and instrumentation expertise/representation and focus on <150 bed hospitals, POL/alternate site, and reference lab markets will serve Sysmex America well as we better meet the needs of our customers," said Michael Messner, Director, Distributor-Primary Care, Sysmex America, Inc.

Sysmex America offers a variety of products to a wide range of segments within the healthcare industry.  In order to reach all customers in the United States, Latin America and Canada, the company partners with a network of distributors who are experts in their respective areas.  

About LABSCO

Laboratory Supply Company was founded by Charles (Charlie) Davis in Louisville, Kentucky in 1972. LABSCO has nine distribution centers and has grown to be the largest privately held distributor of clinical laboratory products in the United States. LABSCO is known for its expertise in the clinical laboratory, but is also a full line distributor of laboratory supplies and instrumentation and medical/surgical products to the physician office laboratory (POL) and other alternate care settings.  LABSCO was recently acquired by Frazier Healthcare.

About Frazier Healthcare

Founded in 1991, Frazier Healthcare is a leading provider of growth equity and venture capital to high growth and emerging healthcare service, biopharma and medical device companies. With over $1.8 billion under management across seven funds, Frazier Healthcare has invested in over 100 companies across the entire developmental spectrum. From seed stage venture investments to leveraged recapitalizations of cash generating companies, Frazier Healthcare has established itself among entrepreneurs and seasoned executives as a preferred partner to help create and grow successful healthcare companies.

About Sysmex America, Inc.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems.  Serving customers for over 40 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide.  For more information about Sysmex, please visit www.sysmex.com/usa.


'/>"/>
SOURCE Sysmex America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. OhioHealth Installs Newest Version of Sysmexs Hematology Middleware, Sysmex WAM(TM) 4.0
2. Sysmex America Adds Industry Veteran to Company Leadership
3. Sysmex America Honored Second Consecutive Year as a Company That Cares
4. Sysmex America Announces Executive Leadership Changes
5. Sysmex America Announces Amerinet Urinalysis Contract
6. Sysmex America Begins Distribution of CellaVision® DM1200
7. Sysmex America and Medica Corporation Announce Distribution Partnership
8. Sysmex America to Launch Complete Cell Image Analysis Portfolio at AACC
9. Sysmex America Awarded National Novation GPO Contract for Automated Urinalysis
10. Sysmex America Announces LabCorp Hematology Automation Agreement
11. Sysmex America Announces Amerinet Hematology Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
Breaking Medicine News(10 mins):